GlaxoSmithKline Pharmaceuticals Limited

NSE:GLAXO.NS

2,561.15 (INR) • At close November 8, 2024
Bedrijfsnaam GlaxoSmithKline Pharmaceuticals Limited
Symbool GLAXO.NS
Munteenheid INR
Prijs 2,561.15
Beurswaarde 433,874,176,900
Dividendpercentage 1.59%
52-weken bereik 1,449.05 - 3,088
Industrie Drug Manufacturers—General
Sector Healthcare
CEO Mr. Bhushan Akshikar
Website https://india-pharma.gsk.com

An error occurred while fetching data.

Over GlaxoSmithKline Pharmaceuticals Limited

GlaxoSmithKline Pharmaceuticals Limited, a healthcare company, researches, develops, manufactures, and sells pharmaceutical medicines and vaccines in India and internationally. The company offers prescription and non-prescription drugs for anti-infective, respiratory, dermatology, nutrition, gastrointestinal, and rare diseases; and consumer healthcare products. It provides its product under the Augmentin, Calpol, Ceftum, Eltroxin, CCM,

Vergelijkbare Aandelen

Lupin Limited logo

Lupin Limited

LUPIN.NS

2,104.6 INR

Ipca Laboratories Limited logo

Ipca Laboratories Limited

IPCALAB.NS

1,558.65 INR

Laurus Labs Limited logo

Laurus Labs Limited

LAURUSLABS.NS

499.35 INR

Syngene International Limited logo

Syngene International Limited

SYNGENE.NS

898.45 INR

Aurobindo Pharma Limited logo

Aurobindo Pharma Limited

AUROPHARMA.NS

1,327.55 INR

Pfizer Limited logo

Pfizer Limited

PFIZER.NS

5,286.85 INR

Fortis Healthcare Limited logo

Fortis Healthcare Limited

FORTIS.NS

620.75 INR

Max Healthcare Institute Limited logo

Max Healthcare Institute Limited

MAXHEALTH.NS

1,079.25 INR

Alkem Laboratories Limited logo

Alkem Laboratories Limited

ALKEM.NS

5,706.5 INR

Dr. Lal PathLabs Limited logo

Dr. Lal PathLabs Limited

LALPATHLAB.NS

3,060.2 INR

Financiële Gegevens

Cijfers zijn in miljoenen (INR)

Cijfers zijn in miljoenen (INR)